Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
27.75
-0.37 (-1.32%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Dianthus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 815 | 154 | - | - |
| Enterprise Value | 455 | -35 | - | - |
| Last Close Price | 27.75 | 10.40 | - | - |
| PE Ratio | - | -1.23 | - | - |
| PS Ratio | 138.91 | 54.53 | - | - |
| PB Ratio | 2.27 | 0.91 | - | - |
| P/FCF Ratio | -14.77 | -4.17 | - | - |
| P/OCF Ratio | -14.80 | -4.18 | - | - |
| EV/Sales Ratio | 110.40 | -12.42 | - | - |
| EV/EBITDA Ratio | -5.58 | 0.73 | - | - |
| EV/EBIT Ratio | -5.57 | 0.73 | - | - |
| EV/FCF Ratio | -7.45 | 0.95 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | - |
| Debt / FCF Ratio | -0.01 | -0.02 | -0.03 | - |
| Asset Turnover | 0.02 | 0.02 | 0.14 | - |
| Quick Ratio | 36.13 | 18.09 | 9.86 | 1.70 |
| Current Ratio | 36.46 | 18.42 | 9.97 | 1.75 |
| Return on Equity (ROE) | -27.33% | -35.92% | -73.25% | - |
| Return on Assets (ROA) | -19.84% | -22.94% | -40.12% | - |
| Return on Capital (ROIC) | -20.67% | -24.69% | -47.27% | - |
| Earnings Yield | -6.96% | -28.26% | - | - |
| FCF Yield | -6.31% | -23.99% | - | - |
| Buyback Yield / Dilution | -413.54% | -489.48% | 78.18% | - |
| Total Shareholder Return | -413.54% | -489.48% | 78.18% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.